MicroVascular Tissues Overview
- Year Founded
-
2014

- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$4.11M
- Investors
-
1
MicroVascular Tissues General Information
Description
Developer of vascular products designed to address vascular deficiencies. The company specializes in stem cell research and human allograft tissue deployment services, providing researchers and physicians with products useful in biological vascular tissue implantation.
Contact Information
Website
www.mvtissues.comCorporate Office
- 6199 Cornerstone Court East
- Suite 109
- San Diego, CA 92121
- United States
Corporate Office
- 6199 Cornerstone Court East
- Suite 109
- San Diego, CA 92121
- United States
MicroVascular Tissues Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC (Series C) | 10-Mar-2023 | $4.11M | Completed | Generating Revenue | ||
2. Early Stage VC (Series B) | 12-Sep-2018 | Completed | Generating Revenue | |||
1. Early Stage VC (Series A) | 28-Aug-2014 | $2.01M | $2.01M | Completed | Startup |
MicroVascular Tissues Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | ||||||||
Series B | ||||||||
Series A | 3,445,076 | $0.001000 | $1.15 | $1.15 | 1x | $1.15 | 24.96% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MicroVascular Tissues Patents
MicroVascular Tissues Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20200353008-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | ||
CA-3086408-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | ||
EP-3737355-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | ||
AU-2019205822-A1 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | ||
EP-3737355-A4 | Compositions and methods for treating nerve injury | Inactive | 08-Jan-2018 | A61K9/0014 |
MicroVascular Tissues Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Pond Capital | Venture Capital | Minority |
MicroVascular Tissues FAQs
-
When was MicroVascular Tissues founded?
MicroVascular Tissues was founded in 2014.
-
Where is MicroVascular Tissues headquartered?
MicroVascular Tissues is headquartered in San Diego, CA.
-
What industry is MicroVascular Tissues in?
MicroVascular Tissues’s primary industry is Discovery Tools (Healthcare).
-
Is MicroVascular Tissues a private or public company?
MicroVascular Tissues is a Private company.
-
What is the current valuation of MicroVascular Tissues?
The current valuation of MicroVascular Tissues is
. -
What is MicroVascular Tissues’s current revenue?
The current revenue for MicroVascular Tissues is
. -
How much funding has MicroVascular Tissues raised over time?
MicroVascular Tissues has raised $11.9M.
-
Who are MicroVascular Tissues’s investors?
Pond Capital has invested in MicroVascular Tissues.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »